JYSZ2400030 | 戈利木单抗注射液 | golimumab | Injection | Biological Products | License Renew | 2024-05-25 | | | | | view |
JYSZ2400029 | 戈利木单抗注射液 | golimumab | Injection | Biological Products | License Renew | 2024-05-25 | | | | | view |
JYSB2400071 | 戈利木单抗注射液 | golimumab | Injection | Biological Products | Supplementary Application | 2024-04-02 | | | | | view |
JYSB2400070 | 戈利木单抗注射液 | golimumab | Injection | Biological Products | Supplementary Application | 2024-04-02 | | | | | view |
JYSB2300162 | 戈利木单抗注射液 | golimumab | Injection | Biological Products | Supplementary Application | 2023-09-15 | | | | | view |
JYSB2300161 | 戈利木单抗注射液 | golimumab | Injection | Biological Products | Supplementary Application | 2023-09-15 | | | | | view |
JYSB2200117 | 戈利木单抗注射液 | golimumab | Injection | Biological Products | Supplementary Application | 2022-07-07 | | | | | view |
JYSB2200116 | 戈利木单抗注射液 | golimumab | Injection | Biological Products | Supplementary Application | 2022-07-07 | | | | | view |
JYSB2101096 | 戈利木单抗注射液 | golimumab | Injection | Biological Products | Supplementary Application | 2021-07-27 | | | | | view |
JYSB2101095 | 戈利木单抗注射液 | golimumab | Injection | Biological Products | Supplementary Application | 2021-07-27 | | | | | view |
JYSB2100090 | 戈利木单抗注射液 | golimumab | Injection | Biological Products | Supplementary Application | 2021-04-01 | Janssen Biologics B.V. | Janssen Biologics BV | In Review | 2021-03-31 | view |
JYSB2100089 | 戈利木单抗注射液 | golimumab | Injection | Biological Products | Supplementary Application | 2021-04-01 | Janssen Biologics B.V. | Janssen Biologics BV | In Review | 2021-05-09 | view |
JYSB2100063 | 戈利木单抗注射液 | golimumab | Injection | Biological Products | Supplementary Application | 2021-02-26 | 西安杨森制药有限公司 | Xian Janssen Pharmaceutical Ltd | Certificate Issued | 2021-12-24 | view |
JYSB2100062 | 戈利木单抗注射液 | golimumab | Injection | Biological Products | Supplementary Application | 2021-02-26 | 西安杨森制药有限公司 | Xian Janssen Pharmaceutical Ltd | Certificate Issued | 2021-12-24 | view |
JYSB2000679 | 戈利木单抗注射液 | golimumab | Injection | Biological Products | Supplementary Application | 2020-12-28 | Janssen Biologics B.V. | Janssen Biologics BV | In Review | 2022-01-27 | view |
JYSB2000678 | 戈利木单抗注射液 | golimumab | Injection | Biological Products | Supplementary Application | 2020-12-28 | 西安杨森制药有限公司 | Xian Janssen Pharmaceutical Ltd | Certificate Issued | 2021-12-17 | view |
JYSB2000334 | 戈利木单抗注射液 | golimumab | Injection | Biological Products | Supplementary Application | 2020-06-28 | Janssen Biologics B.V. | Janssen Biologics BV | Filed | 2020-07-01 | view |
JYSB1900231 | 戈利木单抗注射液 | golimumab | Injection | Biological Products | Supplementary Application | 2019-09-04 | Janssen Biologics B.V. | Janssen Biologics BV | Certificate Issued | 2020-08-18 | view |
JYSB1900121 | 戈利木单抗注射液 | golimumab | Injection | Biological Products | Supplementary Application | 2019-05-31 | Janssen Biologics B.V. | Janssen Biologics BV | Filed | 2019-06-11 | view |
JYSB1900115 | 戈利木单抗注射液 | golimumab | Injection | Biological Products | Supplementary Application | 2019-06-03 | Janssen Biologics B.V. | Janssen Biologics BV | Certificate Issued | 2020-02-27 | view |